The role of oxidative stress and NADPH oxidase in cerebrovascular disease

Trends in Molecular Medicine

Volumn 14, Issue 11, 2008, Pages 495-502

  Chrissobolis, Sophocles ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

BRAIN BLOOD VESSEL; CEREBROVASCULAR DISEASE; DISEASE MODEL; EXPERIMENTAL MODEL; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW;

ANIMALS; CEREBROVASCULAR DISORDERS; DISEASE MODELS, ANIMAL; HUMANS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 54449093276     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2008.09.003     Document Type: Review

References (88)

1. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
2. Lyle A.N., and Griendling K.K. Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 21 (2006) 269-280
3. Lee M.Y., and Griendling K.K. Redox signaling, vascular function, and hypertension. Antioxid. Redox Signal. 10 (2008) 1045-1059
4. Faraci F.M., and Didion S.P. Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1367-1373
5. Pacher P., et al. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
6. Faraci F.M. Reactive oxygen species: influence on cerebral vascular tone. J. Appl. Physiol. 100 (2006) 739-743
7. Faraci F.M. Hydrogen peroxide: watery fuel for change in vascular biology. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1931-1933
8. Wei E.P., et al. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ. Res. 57 (1985) 781-787
9. Faraci F.M., et al. Cerebral vascular effects of angiotensin II: new insights from genetic models. J. Cereb. Blood Flow Metab. 26 (2006) 449-455
10. Fang Q., et al. Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine. J. Appl. Physiol. 100 (2006) 631-636
11. Faraci F.M., et al. Selective cerebral vascular dysfunction in Mn-SOD-deficient mice. J. Appl. Physiol. 100 (2006) 2089-2093
12. Mayhan W.G., et al. Age-related alterations in reactivity of cerebral arterioles: role of oxidative stress. Microcirculation 15 (2008) 225-236
13. Erdos B., et al. Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H1264-H1270
14. Matsumoto T., et al. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushimia Fatty (OLETF) rats. Atherosclerosis 192 (2007) 15-24
15. Didion S.P., et al. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ. Res. 91 (2002) 938-944
16. Baumbach G.L., et al. Hypertrophy of cerebral arterioles in mice deficient in expression of the gene for CuZn superoxide dismutase. Stroke 37 (2006) 1850-1855
17. Beyer A.M., et al. Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension 51 (2008) 867-871
18. Hernanz R., et al. Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin impairment after LPS in rat cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H225-H234
19. Park L., et al. Nox2-derived reactive oxygen species mediate neurovascular dysregulation in the aging mouse brain. J. Cereb. Blood Flow Metab. 27 (2007) 1908-1918
20. Park L., et al. NADPH oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid β peptide. J. Neurosci. 25 (2005) 1769-1777
21. Park L., et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 1347-1352
22. Sun H., et al. Role of NAD(P)H oxidase in alcohol-induced impairment of endothelial nitric oxide synthase-dependent dilation of cerebral arterioles. Stroke 37 (2006) 495-500
23. Zhang F., et al. Superoxide-dependent cerebrovascular effects of homocysteine. Am. J. Physiol. 274 (1998) R1704-R1711
24. Nelson C.W., et al. Oxygen radicals in cerebral ischemia. Am. J. Physiol. 263 (1992) H1356-H1362
25. Girouard H., et al. Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 303-309
26. Girouard H., et al. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through Nox-2-derived radicals. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 826-832
27. Kontos H.A., and Wei E.P. Endothelium-dependent responses after experimental brain injury. J. Neurotrauma 9 (1992) 349-354
28. Erdos B., et al. Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C. Diabetes 53 (2004) 1352-1359
29. Phillips S.A., et al. Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005) R522-R530
30. Dayal S., et al. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35 (2004) 1957-1962
31. Dayal S., et al. Cerebral vascular dysfunction in methionine synthase-deficient mice. Circulation 112 (2005) 737-744
32. Akopov S.E., et al. The endothelium-dependent relaxation of human middle cerebral artery: effects of activated neutrophils. Experientia 48 (1992) 34-36
33. Faraci F.M., and Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol. Rev. 78 (1998) 53-97
34. Faraci F.M. Protecting the brain with eNOS: run for your life. Circ. Res. 99 (2006) 1029-1030
35. Arrick D.M., et al. nNOS-dependent reactivity of cerebral arterioles in type 1 diabetes. Brain Res. 1184 (2007) 365-371
36. Sun H., et al. Influence of chronic alcohol consumption on inward rectifier potassium channels in cerebral arterioles. Microvasc. Res. 75 (2008) 367-372
37. Kim C.D., et al. Gene transfer of Cu/Zn SOD to cerebral vessels prevents FPI-induced CBF autoregulatory dysfunction. Am. J. Physiol. Heart Circ. Physiol. 282 (2002) H1836-H1842
38. Kazama K., et al. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ. Res 95 (2004) 1019-1026
39. Kamii H., et al. Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase. Stroke 30 (1999) 867-871
40. Kim D.E. Vascular NAD(P)H oxidase triggers delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 33 (2002) 2687-2691
41. Kahles T., et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38 (2007) 3000-3006
42. Kondo T., et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J. Neurosci. 17 (1997) 4180-4189
43. Kamada H., et al. Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats. Stroke 38 (2007) 1044-1049
44. Maier C.M., et al. Evaluating therapeutic targets for reperfusion-related brain hemorrhage. Ann. Neurol. 59 (2006) 929-938
45. Baumbach G.L., et al. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension 41 (2003) 50-55
46. Baumbach G.L., et al. Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial NO synthase. Circ. Res. 95 (2004) 822-829
47. Baumbach G.L., et al. Structure of cerebral arterioles in cystathionine β-synthase-deficient mice. Circ. Res. 91 (2002) 931-937
48. Sobey C.G., et al. Potassium channels mediate dilatation of cerebral arterioles in response to arachidonate. Am. J. Physiol. 275 (1998) H1606-H1612
49. Hoffmann O.M., et al. Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis. J. Cereb. Blood Flow Metab. 27 (2007) 1792-1797
50. 2 production in mouse cerebral arteries. Cardiovasc. Res. 73 (2007) 73-81
51. Katusic Z.S., et al. Similar responsiveness of smooth muscle of the canine basilar artery to EDRF and nitric oxide. Am. J. Physiol. 257 (1989) H1235-H1239
52. Kontos H.A., et al. In vivo bioassay of endothelium-derived relaxing factor. Am. J. Physiol. 255 (1988) H1259-H1262
53. Maneen M.J., et al. Peroxynitrite diminishes myogenic activity and is associated with decreased vascular smooth muscle F-actin in rat posterior cerebral arteries. Stroke 37 (2006) 894-899
54. Kunz A., et al. Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J. Neurosci. 27 (2007) 7083-7093
55. Dworakowski R., et al. NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype. Pharmacol. Rep. 60 (2008) 21-28
56. Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. Braz. J. Med. Biol. Res. 37 (2004) 1263-1273
57. Ushio-Fukai M., and Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell. Biochem. 264 (2004) 85-97
58. Williams H.C., and Griendling K.K. NADPH oxidase inhibitors: new antihypertensive agents?. J. Cardiovasc. Pharmacol. 50 (2007) 9-16
59. Martyn K.D., et al. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell. Signal. 18 (2006) 69-82
60. Paravicini T.M., et al. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo. Stroke 35 (2004) 584-589
61. Miller A.A., et al. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ. Res. 97 (2005) 1055-1062
62. Miller A.A., et al. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke 38 (2007) 2142-2149
63. Ago T., et al. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36 (2005) 1040-1046
64. Mayhan W.G., et al. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus. Microcirculation 13 (2006) 567-575
65. Vallet P., et al. Neuronal expression of the NADPH oxidase Nox4, and its regulation in mouse experimental brain ischemia. Neuroscience 132 (2005) 233-238
66. Shin H.K., et al. Impairment of autoregulatory vasodilation by NAD(P)H oxidase-dependent superoxide generation during acute stage of subarachnoid hemorrhage in rat pial artery. J. Cereb. Blood Flow Metab. 22 (2002) 869-877
67. 2 receptor in the cerebrovascular damage of salt-loaded, stroke-prone rats. J. Hypertens. 25 (2007) 861-870
68. Heumuller S., et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51 (2008) 211-217
69. Ishikawa M., et al. Cerebral microvascular responses to hypercholesterolemia. Roles of NADPH oxidase and P-selectin. Circ. Res. 94 (2004) 239-244
70. Wood K.C., et al. Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J. 19 (2005) 989-991
71. Chan S.-L., and Baumbach G.L. Deficiency of Nox-2 prevents cerebral vascular hypertrophy induced by hypertension but not nitric oxide inhibition [abstract]. FASEB J. 21 (2007) 960.14
72. Schrader L.I., et al. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2576-2581
73. Kawahara T., et al. Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol. Biol. 7 (2007) 109
74. Oldendorf W.H., et al. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann. Neurol. 1 (1977) 409-417
75. Zafari A.M., et al. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid. Redox Signal. 1 (1999) 167-179
76. Didion S.P., et al. Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H1697-H1703
77. Mayhan W.G., et al. Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am. J. Physiol. 260 (1991) H319-H326
78. Shi Y., and Vanhoutte P.M. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br. J. Pharmacol. 154 (2008) 639-651
79. Choi S.-H., et al. Genetic deletion or pharmacological inhibition of cycloxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J. 22 (2008) 1491-1501
80. Arrick D.M., et al. Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats. Brain Res. 1209 (2008) 128-135
81. Kuhlmann C.R.W., et al. Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitro. Life Sci. 82 (2008) 1281-1287
82. Sugawara A., et al. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells. Endocrinology 142 (2001) 3125-3134
83. phox message expressions in primary endothelial cells. Metabolism 50 (2001) 3-11
84. Ryan M.J., et al. The PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 43 (2004) 661-666
85. Nakamura T., et al. Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure. Stroke 38 (2007) 3016-3022
86. Didion S.P., et al. Cerebral vascular dysfunction in TallyHo mice: a new model of type II diabetes. Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H1579-H1583
87. Xie H., et al. NF-κB activation plays a role in superoxide-mediated cerebral endothelial dysfunction after hypoxia/reoxygenation. Stroke 36 (2005) 1047-1052
88. McKnight A.A., et al. Oxygen free radicals and the cerebral arteriolar response to group B streptococci. Pediatr. Res. 31 (1992) 640-644